ES2331180T3 - Agente antialergico, su utilizacion para reducir la alergia y metodo para reducir la alergia. - Google Patents

Agente antialergico, su utilizacion para reducir la alergia y metodo para reducir la alergia. Download PDF

Info

Publication number
ES2331180T3
ES2331180T3 ES03738524T ES03738524T ES2331180T3 ES 2331180 T3 ES2331180 T3 ES 2331180T3 ES 03738524 T ES03738524 T ES 03738524T ES 03738524 T ES03738524 T ES 03738524T ES 2331180 T3 ES2331180 T3 ES 2331180T3
Authority
ES
Spain
Prior art keywords
ige
lactic acid
allergy
ova
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03738524T
Other languages
English (en)
Spanish (es)
Inventor
Naoyuki Yamamoto
Yuu Ishida
Izuki Bando
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Soft Drinks Co Ltd
Original Assignee
Calpis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co Ltd filed Critical Calpis Co Ltd
Application granted granted Critical
Publication of ES2331180T3 publication Critical patent/ES2331180T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES03738524T 2002-06-26 2003-06-26 Agente antialergico, su utilizacion para reducir la alergia y metodo para reducir la alergia. Expired - Lifetime ES2331180T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002-185897 2002-06-26
JP2002185897A JP4212838B2 (ja) 2002-06-26 2002-06-26 抗アレルギー剤

Publications (1)

Publication Number Publication Date
ES2331180T3 true ES2331180T3 (es) 2009-12-23

Family

ID=29996753

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03738524T Expired - Lifetime ES2331180T3 (es) 2002-06-26 2003-06-26 Agente antialergico, su utilizacion para reducir la alergia y metodo para reducir la alergia.

Country Status (21)

Country Link
US (2) US20050214270A1 (https=)
EP (1) EP1555028B1 (https=)
JP (1) JP4212838B2 (https=)
KR (2) KR20080018287A (https=)
CN (1) CN100567489C (https=)
AT (1) ATE444074T1 (https=)
AU (1) AU2003246204B2 (https=)
BR (1) BR0312052A (https=)
CA (1) CA2490896C (https=)
DE (1) DE60329516D1 (https=)
DK (1) DK1555028T3 (https=)
ES (1) ES2331180T3 (https=)
MX (1) MXPA04012636A (https=)
NO (1) NO20050411L (https=)
PL (1) PL204931B1 (https=)
PT (1) PT1555028E (https=)
RU (1) RU2336886C2 (https=)
TW (1) TW200402304A (https=)
UA (1) UA86349C2 (https=)
WO (1) WO2004002501A1 (https=)
ZA (1) ZA200500715B (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1010487A6 (nl) 1996-06-11 1998-10-06 Unilin Beheer Bv Vloerbekleding bestaande uit harde vloerpanelen en werkwijze voor het vervaardigen van dergelijke vloerpanelen.
JP4688457B2 (ja) * 2004-09-10 2011-05-25 四国乳業株式会社 免疫増強組成物
JP4823503B2 (ja) * 2004-10-14 2011-11-24 ジェンモント バイオテック インコーポレイテッド Ｌａｃｔｏｂａｃｉｌｌｕｓｆｅｒｍｅｎｔｕｍの新規微生物株ＧＭ−０９０、およびＩＦＮ−γ分泌の刺激および／またはアレルギーの処置のためのその使用。
US7351572B2 (en) 2004-10-15 2008-04-01 Genmont Biotech Inc. Microorganism strain GM-090 of Lactobacillus fermentum and its use for stimulating IFN-γ secretion and/or treating allergy
TW200637908A (en) 2005-01-04 2006-11-01 Calpis Co Ltd Method for preparation of lactic acid bacterium having anti-allergic activity
KR101312745B1 (ko) 2005-03-03 2013-09-27 가부시키가이샤 메이지 면역기능 조정제
TW200700074A (en) * 2005-03-04 2007-01-01 Calpis Co Ltd Inducer of t cell apoptosis
ES2463724T3 (es) 2005-10-11 2014-05-29 Probiotical S.P.A. Procedimiento de preparación de cultivos bacterianos probióticos analérgicos y uso relacionado
EP1961309A4 (en) 2005-12-06 2010-01-20 Otsuka Pharma Co Ltd EMBRYONIC AXIS FERMENTATION PRODUCT OF SOYBEAN CONTAINING EQUOL, AND METHOD FOR PRODUCING THE SAME
MX2009003260A (es) * 2006-10-02 2009-05-11 Danisco Probioticos para el uso en la reduccion de la incidencia y duracion de la enfermedad.
EA016734B1 (ru) * 2006-12-21 2012-07-30 Калпис Ко., Лтд. СРЕДСТВА ДЛЯ СТИМУЛЯЦИИ ПРОДУЦИРОВАНИЯ IgA НА ОСНОВЕ БАКТЕРИЙ LACTOBACILLUS AMYLOVORUS И ШТАММ БАКТЕРИЙ LACTOBACILLUS AMYLOVORUS CP1750 FERM BP-10532
CN101796187A (zh) 2007-07-04 2010-08-04 龟甲万株式会社 乳酸菌来源的双链rna
RU2431663C2 (ru) * 2008-01-28 2011-10-20 Общество с ограниченной ответственностью "ИнноПроб" (ООО "ИнноПроб") ИММУНОБИОЛОГИЧЕСКОЕ ПРОТИВОАЛЛЕРГИЧЕСКОЕ СРЕДСТВО (ВАРИАНТЫ) И ШТАММ Lactobacillus acidophilus 100 аш ПА, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПРОИЗВОДСТВА ИММУНОБИОЛОГИЧЕСКОГО ПРОТИВОАЛЛЕРГИЧЕСКОГО СРЕДСТВА
US20100055082A1 (en) * 2008-09-04 2010-03-04 Jacques Alain Bauer Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
RU2460781C2 (ru) * 2009-01-29 2012-09-10 Общество с ограниченной ответственностью "ИнноПроб" (ООО "ИнноПроб") Иммунобиологическое противоаллергическое средство (варианты), штамм lactobacillus acidophilus, используемый при приготовлении иммунобиологического противоаллергического средства
RU2393214C1 (ru) * 2009-01-29 2010-06-27 Общество с ограниченной ответственностью "ИнноПроб"(ООО"ИнноПроб") Иммунобиологическое противоаллергическое средство (варианты), штамм lactobacillus acidophilus nkjc, штамм lactobacillus acidophilus jch, штамм lactobacillus acidophilus kaa
EP2332557A1 (en) 2009-12-08 2011-06-15 Campina Nederland Holding B.V. Probiotic lactic acid bacteria
TW201300526A (zh) * 2011-03-25 2013-01-01 Calpis Co Ltd 培養基之製造方法及該方法所製造之培養基
KR101166798B1 (ko) 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
US9636326B2 (en) 2011-12-28 2017-05-02 Maruha Nichiro Corporation Chlorophyll c containing degranulation suppressor
JP6149228B2 (ja) * 2013-04-11 2017-06-21 アサヒグループホールディングス株式会社 免疫調節作用を有する乳酸菌のスクリーニング方法
JP5927730B2 (ja) * 2013-04-11 2016-06-01 アサヒグループホールディングス株式会社 免疫調節作用を有する乳酸菌のスクリーニング方法
KR101688224B1 (ko) * 2015-05-01 2016-12-20 일동바이오사이언스(주) 관절염 예방 및 치료 효과를 갖는 아이디-씨비티5101(id-cbt5101) 및 이의 용도
CN109195612A (zh) * 2016-05-09 2019-01-11 拜奥加亚公司 可用于过敏反应治疗的细菌菌株的选择
EP3511409A4 (en) 2016-09-12 2020-05-06 Ichibiki Co Ltd. SALT-TOLERANT LACTOBACILLA, SALT-TOLERANT LACTOBACIL CULTURE AND IMMUNOSTIMULATOR
EP3738599B1 (en) 2018-01-12 2023-12-27 GI Innovation, Inc. Composition comprising probiotics and polypeptide having binding affinity for ige and use thereof
JP2021059522A (ja) * 2019-03-20 2021-04-15 キユーピー株式会社 アレルギー症状改善用組成物
CN116035187B (zh) * 2022-12-30 2025-02-07 江南大学 一种使用植物乳杆菌发酵降低苦杏仁蛋白致敏性的方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US575270A (en) * 1897-01-12 Combined cover and stand for books
US635796A (en) * 1898-03-07 1899-10-31 Isaac Moore Manifolding sales-book.
US959766A (en) * 1909-05-14 1910-05-31 Lewis Life Wire-fastener.
US1048383A (en) * 1911-06-16 1912-12-24 Charles J Carroll Manifolding sales-book.
US1201377A (en) * 1916-07-24 1916-10-17 William S Staiars Protector-tablet.
US1915974A (en) * 1930-07-10 1933-06-27 American Sales Book Co Ltd Retaining device
US2218297A (en) * 1936-07-14 1940-10-15 Randzio Reinhold Bookkeeping system
US2806715A (en) * 1956-06-29 1957-09-17 Henry O Smith Illuminated note pad holder
JPH0634709B2 (ja) * 1985-12-03 1994-05-11 カルピス食品工業株式会社 新規乳酸菌
US4787852A (en) * 1987-04-24 1988-11-29 Melnick David W Multicolor interactive notepad
US4840406A (en) * 1987-05-29 1989-06-20 Dennison Manufacturing Company Method of mounting index tabs upon stenographic notebooks
US4816884A (en) * 1987-07-20 1989-03-28 International Business Machines Corporation High density vertical trench transistor and capacitor memory cell structure and fabrication method therefor
AU1076595A (en) * 1993-11-23 1995-06-13 Kabushiki Kaisha Wado Doctors Group Intestinal flora improver composition, and apparatus and system for producing the same
JP2992945B2 (ja) * 1994-03-11 1999-12-20 カルピス株式会社 ラクトバチルス・アシドフィルス乳酸菌
CN1110147A (zh) * 1994-04-09 1995-10-18 山田武敏 抗变态反应组合物
JPH092959A (ja) * 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
JP4064480B2 (ja) * 1996-10-11 2008-03-19 ハウスウェルネスフーズ株式会社 ＩｇＧ抗体産生抑制剤
JPH10309178A (ja) * 1997-05-09 1998-11-24 Wakamoto Pharmaceut Co Ltd ビフィズス菌を有効成分とする抗アレルギー剤および醗酵食品
USD393841S (en) * 1997-05-27 1998-04-28 Fujitsu Limited Renewal of document to make alterations icon for a display screen
US6657642B1 (en) * 1997-07-03 2003-12-02 International Business Machines Corporation User interactive display interfaces with means for interactive formation of combination display objects representative of combined interactive functions
JP2000086524A (ja) * 1998-09-05 2000-03-28 Shadan Seirankai 生きた腸内細菌を含有する抗アレルギー剤
JP2000095697A (ja) * 1998-09-18 2000-04-04 Advance Co Ltd 抗アレルギー剤
JP2000239175A (ja) * 1999-02-18 2000-09-05 Calpis Co Ltd 抗アレルギー剤
US6217443B1 (en) * 1999-03-11 2001-04-17 Leonard C. Green, Jr. Carbonless paper notepad
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
AUPQ415899A0 (en) * 1999-11-19 1999-12-16 Vasse Research Institute Pty Ltd Compositions for and methods of treatment of allergic diseases
GB2365659B (en) * 2000-02-25 2002-07-24 Red Fig Ltd Serving hypermedia documents
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
JP3944076B2 (ja) * 2000-08-25 2007-07-11 わかもと製薬株式会社 乳酸菌含有プロバイオティクス製品
US20030021624A1 (en) * 2001-06-29 2003-01-30 Dorsey Cheryl L. Article and method for making a notebook with permanent and disposable elements
DE20202562U1 (de) * 2002-02-19 2002-05-23 Orthomol pharmazeutische Vertriebs GmbH, 40764 Langenfeld Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika

Also Published As

Publication number Publication date
RU2005101766A (ru) 2005-08-20
KR20050014879A (ko) 2005-02-07
DE60329516D1 (de) 2009-11-12
ATE444074T1 (de) 2009-10-15
TW200402304A (en) 2004-02-16
WO2004002501A1 (ja) 2004-01-08
MXPA04012636A (es) 2005-03-23
KR20080018287A (ko) 2008-02-27
UA86349C2 (ru) 2009-04-27
EP1555028A4 (en) 2007-06-06
US20050214270A1 (en) 2005-09-29
CA2490896A1 (en) 2004-01-08
PL375158A1 (en) 2005-11-28
JP4212838B2 (ja) 2009-01-21
EP1555028B1 (en) 2009-09-30
CN1678330A (zh) 2005-10-05
PL204931B1 (pl) 2010-02-26
TWI304736B (https=) 2009-01-01
KR100836727B1 (ko) 2008-06-10
EP1555028A1 (en) 2005-07-20
PT1555028E (pt) 2010-01-05
HK1081432A1 (zh) 2006-05-19
AU2003246204A1 (en) 2004-01-19
BR0312052A (pt) 2005-03-29
CA2490896C (en) 2011-02-01
NO20050411L (no) 2005-01-25
JP2004026729A (ja) 2004-01-29
RU2336886C2 (ru) 2008-10-27
US8003092B2 (en) 2011-08-23
AU2003246204B2 (en) 2007-07-12
CN100567489C (zh) 2009-12-09
US20090047264A1 (en) 2009-02-19
ZA200500715B (en) 2006-08-30
DK1555028T3 (da) 2010-02-01

Similar Documents

Publication Publication Date Title
ES2331180T3 (es) Agente antialergico, su utilizacion para reducir la alergia y metodo para reducir la alergia.
AU2019274351B2 (en) Lactobacillus gasseri KBL697 strain and use thereof
CA2257077C (en) Treatment of diarrhea
US11590180B2 (en) Bifidobacterium lactis GKK2, a composition comprising thereof and its use for improving allergic asthma
JPH092959A (ja) ＩｇＥ抗体産生抑制剤および抗アレルギー剤
Bisson et al. Preventive effects of different probiotic formulations on travelers’ diarrhea model in wistar rats: preventive effects of probiotics on TD
JP4002187B2 (ja) 抗ふけ菌免疫抗体及びその用途
CN111700917B (zh) 一种用于预防和/或治疗特应性皮炎的产品
Kawase et al. Orally administrated Lactobacillus gasseri TMC0356 and Lactobacillus GG alleviated nasal blockage of guinea pig with allergic rhinitis
JPH09263539A (ja) 抗真菌作用を有する皮膚疾患治療剤
RU2793833C1 (ru) Способ комплексной терапии пациентов детского возраста с вирусной инфекцией с использованием продуктов пробиотического питания
Tansho et al. Production of anti‐Candida antibodies in mice with gut colonization of Candida albicans
HK1081432B (en) Antiallergic agent, utilization thereof in the manufacture of a medicament for reducing allergy
De Petrino et al. The effect of Lactobacillus casei on an experimental model of atopy
Karacic et al. Effect of oral vs. parenteral cyclophosphamide on in vitro IgA and IgG production by murine Peyer's patches and cultured jejunal fragments
JP2024506965A (ja) 組成物およびその使用
Bernstein et al. Allergy abstracts
Hwang et al. Establishment of gnotobiotic miniature swine for xenotransplantation research program in Konkuk University, Seoul, Korea